Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by theinvestor22on Mar 02, 2021 10:45am
150 Views
Post# 32694424

RE:RE:RE:RE:FINANCIALS RELEASED / READ BELOW

RE:RE:RE:RE:FINANCIALS RELEASED / READ BELOWRe the highlighted portion, I was thinking the exact same thing.  Over the coming quarters, GM% for SaaS should approach guided numbers and regular expenses should go down somewhat.

lscfa wrote:

More likely they still are not allocating any costs to the SAAS segment and the costs of devices includes something more than the inventory costs.

 

Dec 2020

SAAS

Devices

Total

Revenue

218,022

199,792

417,814

Cost of rev

0

199,792

199,792

 


 

theinvestor22 wrote: Just a couple of quick, but I think important, points to highlight on your posting (see below).  Firstly, there was very good growth in SaaS.  Secondly, while I think it's still a bit early to get a firm handle on the underlying gross margin percentage for the SaaS part of the business, your calc points to a very high number (97%) for the quarter.
 

 

lscfa wrote:

They dropped the guidance about being cash flow positive in March qtr but most investors assumed they would miss that. Not breaking down revenue is still distorting things. It looks like SAAS revenue grew 168% from last qtr.

assuming no profit on device sales:

Sept 2020

SAAS

Devices

Total

Revenue

87,218

113,684

200,902

Cost of rev

0

113,684

113,684

 

 

 

 

Dec 20

SAAS

Devices

Total

Revenue

225,011

192,803

417,814

Cost of rev

6,989

192,803

199,792

 

 


 




<< Previous
Bullboard Posts
Next >>